CVE-2010-1137

Description

Cross-site scripting (XSS) vulnerability in WebAccess in VMware VirtualCenter 2.0.2 and 2.5 and VMware ESX 3.0.3 and 3.5, and the Server Console in VMware Server 1.0, allows remote attackers to inject arbitrary web script or HTML via the name of a virtual machine.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.97% Top 25%
Vendor Advisory gentoo.org Vendor Advisory vmware.com Vendor Advisory vmware.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/bid/39037 vdb entry
http://security.gentoo.org/glsa/glsa-201209-25.xml vendor advisory
https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A6863 signature vdb entry
http://lists.vmware.com/pipermail/security-announce/2010/000086.html patch vendor advisory mailing list
http://www.vmware.com/security/advisories/VMSA-2010-0005.html patch vendor advisory
http://www.securitytracker.com/id?1023769 vdb entry

Frequently Asked Questions

What is the severity of CVE-2010-1137?
CVE-2010-1137 has been scored as a medium severity vulnerability.
How to fix CVE-2010-1137?
To fix CVE-2010-1137, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2010-1137 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2010-1137 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.